18F-FDG PET/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

18F-FDG PET/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors

Published:2018-07-22 Issue:2 Volume:60 Page:367-375
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Castello Angelo¹^ORCID,Grizzi Fabio²,Qehajaj Dorina²,Rahal Daoud³,Lutman Fabio⁴,Lopci Egesta¹

Affiliation:

1. Nuclear Medicine Department, Humanitas Clinical and Research Hospital, Rozzano, MI, Italy;

2. Immunology and Inflammation, Humanitas Clinical and Research Hospital, Rozzano, MI, Italy;

3. Pathology Department, Humanitas Clinical and Research Hospital, Rozzano, MI, Italy;

4. Radiology Department, Humanitas Clinical and Research Hospital, Rozzano, MI, Italy

Funder

AIRC

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1488254

Reference33 articles.

1. Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and management

2. Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

3. Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma

4. Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure

5. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Response to Immunotherapy in Patients with Hodgkin Lymphoma: Towards Quantifying Changes in Tumor Burden Using FDG-PET/CT;Journal of Clinical Medicine;2023-05-16

2. PET/CT in Non-Hodgkin Lymphoma: An Update;Seminars in Nuclear Medicine;2023-05

3. PET/CT in Hodgkin Lymphoma: An Update;Seminars in Nuclear Medicine;2023-05

4. FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects;Cancers;2023-02-07

5. Prognostic role of pretreatment 18F-FDG PET/CT and hematological parameters in relapsed/refractory Hodgkin lymphoma patients treated with immune checkpoint inhibitors and chemotherapy: a dual-center cohort study;BMC Medical Imaging;2023-01-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3